COMMUNIQUÉS West-GlobeNewswire

Philips global sleep survey shows we want better sleep, but only if it comes easily
07/03/2019
44% of adults surveyed globally admit their sleep has worsened in the last five years 8 in 10 adults worldwide want to improve the quality of their sleep, but the majority (60%) have not sought help from a medical [...]
Atara Biotherapeutics to Participate in Upcoming Conferences
07/03/2019
SOUTH SAN FRANCISCO, Calif., March 07, 2019 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with [...]
Medifirst Solutions Provides a Company Update
07/03/2019
Freehold, NJ, March 07, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- MEDIFIRST SOLUTIONS, INC. (OTC: MFST) (the “Company” or “Medifirst”), a provider of innovative laser technology with its FDA 510(k) cleared Infrared [...]
Xbrane Biopharma and Redeye informs of changed time schedule at the company presentation in Malmö, 7th of March
07/03/2019
Press release 2019-03-07 Xbrane Biopharma informs that the company presentation will be scheduled earlier than previously communicated. The starting time of the presentation will be at 18.00. To see the live broadcast, [...]
Progenics Pharmaceuticals Sets Fourth Quarter and Full-Year 2018 Financial Results and Business Update Call for March 14
07/03/2019
NEW YORK, March 07, 2019 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX), an oncology company developing innovative medicines and imaging analysis technology for targeting and treating cancer, today [...]
Cytori Files Pre-submission Request for New Drug Application
07/03/2019
Doxorubicin Hydrochloride Cytori - First Intended for European Market SAN DIEGO, March 07, 2019 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (NASDAQ: CYTX) today announced that it officially filed a formal new drug [...]
Quotient Limited to Participate in the Cowen and Company 39th Annual Health Care Conference
07/03/2019
JERSEY, Channel Islands, March 07, 2019 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company’s Chief Financial Officer, Chris Lindop, will present [...]
For The Earth Announces Launch of New Line of Premium CBD-Infused Topicals
07/03/2019
PHOENIX, March 07, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- For The Earth Corporation (the "Company" or "FTEG") (OTCMKTS: FTEG) is thrilled to announce the launch of its new line of premium pharmaceutical grade anti- [...]
Trinity Biotech announces Quarter 4 and Fiscal Year 2018 Financial Results
07/03/2019
DUBLIN, Ireland, March 07, 2019 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced [...]
Wishbone Medical Breaks Ground With Foot & Ankle Solutions for Children
07/03/2019
New technology optimized by sterile, single-use packaging WARSAW, Ind., March 07, 2019 (GLOBE NEWSWIRE) -- WishBone Medical expands the pediatric orthopedic market with leading edge foot and ankle solutions in sterile, [...]
Vystar Gains 1st Institutional Investor with $200K Investment at $0.15/Share
07/03/2019
WORCESTER, Mass., March 07, 2019 (GLOBE NEWSWIRE) -- Vystar Corporation , (OTC Pink: VYST) a family of eco-friendly brands including Vytex® Natural Rubber Latex (NRL) and RxAir® air purification products, announced that [...]
Auris Medical to Report Fourth Quarter and Full Year 2018 Financial Results and Provide Business Update on Thursday, March 14, 2019
07/03/2019
Zug, Switzerland, March 07, 2019 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and central nervous [...]
Allena Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business Update
07/03/2019
-- Achieved Alignment with U.S. Food and Drug Administration (FDA) on Phase 3 URIROX TM Program and Accelerated Approval Strategy for Reloxaliase -- -- Phase 3 URIROX-1 and URIROX-2 Trials Ongoing; URIROX-1 Topline Data [...]
Catalyst Biosciences Reports Fourth Quarter and Full-Year 2018 Operating & Financial Results and Provides a Corporate Update
07/03/2019
Completed enrollment of the MarzAA SQ Phase 2 trial and demonstrated safety and clinical efficacy, with >90% reduction in bleeding Completed a full immunogenicity analysis for DalcA, plan to initiate a Phase 2b 28- [...]
Seelos Therapeutics Announces Acquisition of an Exclusive License to Intellectual Property from The UC Regents to Potential Disease-Modifying Parkinson's Disease Therapy Created at UCLA
07/03/2019
Well-Validated, Pre-Clinical Success Shown in the Reduction of Alpha-Synuclein New Compound Expands Seelos’ Parkinson's Portfolio NEW YORK, March 07, 2019 (GLOBE NEWSWIRE) -- Seelos Therapeutics, Inc. (NASDAQ: SEEL), a [...]
Avadel Pharmaceuticals to Report Fourth Quarter and Full Year 2018 Financial Results
07/03/2019
DUBLIN, Ireland, March 07, 2019 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on developing FT218 for sleep disorders, today announced that it will host a conference call and live [...]
Neos Therapeutics to Host Fourth Quarter and Year-End 2018 Financial and Operating Results Conference Call on March 14th, 2019
07/03/2019
DALLAS and FORT WORTH, Texas, March 07, 2019 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq: NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative extended-release (XR [...]
Foamix Announces FDA Acceptance of New Drug Application for FMX101 Minocycline Foam for the Treatment of Moderate-to-Severe Acne
07/03/2019
PDUFA Target Action Date of October 20th, 2019 REHOVOT, Israel, and BRIDGEWATER, N.J., March 07, 2019 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (Nasdaq: FOMX), a clinical stage specialty pharmaceutical company [...]
AMAG Pharmaceuticals Presents New Data on Bremelanotide and Hypoactive Sexual Desire Disorder at the ISSWSH/ISSM Joint Meeting
07/03/2019
WALTHAM, Mass., March 07, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) announced today that new and encore data related to bremelanotide and Hypoactive Sexual Desire Disorder (HSDD) will be [...]

Pages